Skip to content

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2018-004140-28-FR
Enrollment
3
Registered
2018-11-29
Start date
2019-03-05
Completion date
Unknown
Last updated
2020-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Product Name: L-méthionine Product Code: préparation magistrale Pharmaceutical Form: Capsule INN or Proposed INN: L-METHIONINE CAS Number: 63-68-3

Sponsors

ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS (AP-HP)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: NA Are the trial subjects under 18? yes Number of subjects for this age range: 3 F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

MeasureTime frame
Main Objective: NA;Secondary Objective: NA;Primary end point(s): NA;Timepoint(s) of evaluation of this end point: NA

Secondary

MeasureTime frame
Secondary end point(s): NA;Timepoint(s) of evaluation of this end point: NA

Countries

France

Contacts

Public ContactDRCI Hôpital Saint Louis

ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS (AP-HP)

sylvie.prieur@aphp.fr

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026